This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Dec 8;118(24):6232-4.

doi: 10.1182/blood-2011-10-383893.

ITP: tolerance lost

Patrick F Fogarty¹

Affiliations

PMID: 22161847
DOI: 10.1182/blood-2011-10-383893

Free article

Comment

ITP: tolerance lost

Patrick F Fogarty. Blood. 2011.

Free article

. 2011 Dec 8;118(24):6232-4.

doi: 10.1182/blood-2011-10-383893.

Author

Patrick F Fogarty¹

Affiliation

¹ University of Pennsylvania, USA.

PMID: 22161847
DOI: 10.1182/blood-2011-10-383893

No abstract available

PubMed Disclaimer

Comment on

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Cuker A, Coles AJ, Sullivan H, Fox E, Goldberg M, Oyuela P, Purvis A, Beardsley DS, Margolin DH. Cuker A, et al. Blood. 2011 Dec 8;118(24):6299-305. doi: 10.1182/blood-2011-08-371138. Epub 2011 Sep 29. Blood. 2011. PMID: 21960587 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems